United Therapeutics (NASDAQ:UTHR) Earns “Buy” Rating from HC Wainwright
United Therapeutics (NASDAQ:UTHR – Get Free Report)‘s stock had its “buy” rating reaffirmed by HC Wainwright in a research note issued to investors on Monday,Benzinga reports. They currently have a $425.00 price objective on the biotechnology company’s stock. HC Wainwright’s target price suggests a potential upside of 44.06% from the stock’s previous close. HC Wainwright […]
United Therapeutics (NASDAQ:UTHR – Get Free Report)‘s stock had its “buy” rating reaffirmed by HC Wainwright in a research note issued to investors on Monday,Benzinga reports. They currently have a $425.00 price objective on the biotechnology company’s stock. HC Wainwright’s target price suggests a potential upside of 44.06% from the stock’s previous close. HC Wainwright […]
